THE LATEST
06 AUG 2026 · HealthSnap announces $25M secured growth financing · AI and primary care expansion
HEALTHCARE / THE FOLLOW-THROUGH

HealthSnap makes the space between visits count

A connected cuff can send a number. HealthSnap builds the clinical follow-through that gives that number a job.

Advertisement

The blood pressure cuff has a modest job. It squeezes an arm, produces two numbers, and waits to be put away. HealthSnap’s business begins with a question the cuff cannot answer: what happens next? A reading can reach a clinician instantly. Whether anyone has the time, context, and responsibility to act on it is a different problem.

The story in three readings
  • HealthSnap connects home measurements to care teams, clinical workflows, and reimbursement.
  • Its customers are healthcare organizations; patients enter through their providers.
  • The useful innovation is the follow-through: devices, people, software, and payment working together.

That distinction explains why a company associated with connected devices spends so much effort on nurses, documentation, and billing. Remote monitoring creates information. Chronic care management supplies the repeated conversations and coordination that can make information useful. HealthSnap sells healthcare organizations a way to put those activities into the same working day.

A connection without a password

Founded in 2015, HealthSnap grew out of University of Miami research into lifestyle and health. Its current leadership identifies three co-founders: chief executive Samson Magid, chief operating officer Chase Preston, and chief science officer Wesley Smith. The company’s origins include a painfully ordinary healthcare experience: relatives whose needs were poorly served between appointments. The absence of care was part of the problem they wanted to solve.

The product makes one revealing design choice. Its preconfigured cellular devices do not require patients to own a smartphone or connect to home Wi-Fi. For someone managing a chronic condition, this removes a small technology project from an already demanding routine. A blood pressure reading can travel from the kitchen table to a care team without a Bluetooth tutorial.

HealthSnap co-founders Samson Magid, Chase Preston and Wesley Smith standing together in matching company shirts
Three founders, one dress code. From left: Samson Magid, Chase Preston and Wesley Smith. The harder coordination happens between clinic visits.

Devices are only the entrance. HealthSnap combines remote patient monitoring, chronic care management, principal care management, and, more recently, advanced primary care management. In practical terms, that means collecting measurements, supporting care plans, coordinating follow-up, and helping providers document the work. Its platform also brings patient information into electronic health record workflows and gives organizations a view across their patient populations.

Somebody has to make the call

The most informative description of the service appears in a published study of HealthSnap’s hypertension program. Registered nurse care navigators watched incoming readings. They contacted patients when measurements fell outside their target range or when data stopped arriving for more than three consecutive days. Monthly conversations covered physician-approved care goals. Monitoring included noticing silence.

For a hospital executive, that is an operating model as much as a software purchase. Staff shortages do not disappear when a dashboard arrives. HealthSnap offers care management services alongside its technology, allowing organizations to share the clinical workload. Its stated culture emphasizes empathy and ownership, qualities that have a concrete test here: whether a patient gets a useful conversation after a concerning result.

Other companies see the same opportunity. Cadence combines remote chronic care with clinical teams and AI; Prevounce offers software, cellular devices, and care management services. HealthSnap’s positioning rests on its particular combination of enterprise integration, multiple care programs, clinical support, and billing tools. Buyers should compare how those pieces work inside their own organization. A feature list alone cannot settle that question.

The numbers deserve a second reading

A 2024 peer-reviewed retrospective analysis followed 6,595 participants at Prisma Health Upstate and Virginia Cardiovascular Specialists. Average systolic blood pressure moved from about 135 to 127.8 mmHg. That is encouraging evidence of an association. The study lacked a randomized control group, and two authors disclosed financial relationships with HealthSnap. It cannot isolate how much improvement came from monitoring itself.

Published cohort · 2024

Average systolic blood pressure

Baseline
135
Follow-up
127.8
mmHg · bars start at zero · scale 0-150
Good direction. A careful claim. The 6,595-patient analysis was observational, with roughly 289 days of follow-up for blood pressure control.

A separate company outcomes report examined 41,940 patients, requiring at least 90 days of participation and transmission on at least half the days. Those rules matter. They describe people who stayed engaged enough to be measured. A provider considering the service should ask how enrollment, missed readings, and withdrawal affect results across everyone offered the program.

Care needs a payment mechanism

HealthSnap’s 2021 investor summary described a monthly fee per enrolled patient, including a preconfigured device, with additional charges tied to clinical time for shared care services. That document explains the commercial logic, rather than establishing today’s price. Providers buy infrastructure and capacity; reimbursement helps support the care delivered through it. Device cost and patient insurance obligations are separate questions.

The same summary reported a monthly cash burn of $175,000 at that early stage. Building the operation required capital: a $9 million Series A in May 2023 and a $25 million Series B in February 2024 followed. In August 2026, HealthSnap announced another $25 million, this time a senior secured financing facility to refinance debt and support expansion.

Customer adoption supplies a more tangible test. Sentara began its rollout at 12 primary care sites in August 2025, with plans to extend access to approximately 389 providers and 85,000 eligible patients. Eligible is the crucial word: that was potential reach, not an enrollment count. University Hospitals separately launched a hypertension program with a planned rollout across nearly 100 practice sites.

The next bottleneck is attention

By August 2026, HealthSnap reported more than 80,000 active patient programs across 200 healthcare organizations. It was adding AI support for clinical summaries, quality review, nurse training, and routine patient interactions. The company says clinical teams retain final judgment. Its next challenge is making a growing stream of information manageable without weakening the human response.

“We believe in the power of prevention over treatment.”

HealthSnap’s stated company philosophy

The transferable lesson is operational: remove setup friction, assign responsibility for follow-up, and make the ongoing work financially supportable. The approach depends on patients taking readings, dependable connectivity, clinical capacity, and a workable payment model. Without those conditions, a transmitted number can remain an unanswered message. HealthSnap’s proposition is that the response can become a service providers reliably deliver.